Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?

被引：0
|
作者：
Hachulla, E. [1 ]
机构：
[1] Hop Claude Huriez, Ctr Reference Malad Autoimmunes & Autoinflammatoi, Serv Med Interne & Immunol Clin, F-59037 Lille, France
来源：
REVUE DE MEDECINE INTERNE | 2019年 / 40卷 / 12期
关键词：
Nintedanib; Systemic sclerosis; Interstitial lung disease; SCLERODERMA LUNG; CONTROLLED-TRIAL; PLACEBO; CYCLOPHOSPHAMIDE;
D O I：
10.1016/j.revmed.2019.08.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：775 / 777
页数：3
相关论文
共 50 条
  • [41] TREATMENT WITH NINTEDANIB IN SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE: SAFETY AND EFFECTIVENESS AFTER ONE YEAR IN A REAL-LIFE COHORT
    Corada, J.
    Guillen-Del-Castillo, A.
    Blazquez, I.
    Codina, C.
    Anton, A.
    Mestre, J.
    Gil, A.
    Perurena-Prieto, J.
    Ojanguren, I.
    Villar, A.
    Simeon Aznar, C. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1012 - 1013
  • [42] RITUXIMAB FOR THE TREATMENT OF SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: A CASE SERIES
    Ananyeva, L.
    Desinova, O.
    Starovoytova, M.
    Koneva, O.
    Yutkina, N.
    Onsyannikova, O.
    Volkov, A.
    Aleksandrova, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 648 - 648
  • [43] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
  • [44] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Wilhalme, Holly
    Tashkin, Donald P.
    Kim, Grace Hyun J.
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael D.
    Assassi, Shervin
    ARTHRITIS CARE & RESEARCH, 2025,
  • [45] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth
    Wilhalme, Holly
    Tashkin, Donald
    Kim, Grace
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3448 - 3449
  • [46] Lung ultrasound and high-resolution computed tomography quantitative variations during nintedanib treatment for systemic sclerosis-associated interstitial lung disease
    Di Battista, Marco
    Delle Sedie, Andrea
    Romei, Chiara
    Tavanti, Laura
    Da Rio, Mattia
    Morganti, Riccardo
    Della Rossa, Alessandra
    Mosca, Marta
    RHEUMATOLOGY, 2023, 63 (11) : 3091 - 3097
  • [47] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [48] Lung transplantation for systemic sclerosis-associated interstitial lung disease
    Le Pavec, J.
    Launay, D.
    Cottin, V.
    Reynaud-Gaubert, M.
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 : E73 - E79
  • [49] Lung Function And Survival In Systemic Sclerosis Associated Interstitial Lung Disease
    Shadly, S. M.
    Johnson, S. R.
    Chau, C.
    Marras, T. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [50] Nailfold Capillaroscopy in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib
    Smith, Vanessa
    Denton, Christopher
    Herrick, Ariane
    Ittrich, Carina
    Alves, Margarida
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1241 - 1243
12345